Dr Shambo Samrat Samajdar MD DM- Clinical Pharmacology

24/06/2026

Conference: 13th Academia International Conclave
Organised by: Diabetes Care Foundation of India, Nagpur, and Diabetes Care n’ Research Centre
Dates: 19–21 June 2026
Venue: Hotel Centre Point, Nagpur

It was a privilege to moderate Flight No. 19: Workshop on Artificial Intelligence, held from 10:15 a.m. to 11:15 a.m. as part of the National AI Workshop in Diabetes.

Along with Dr Alok Modi, I had the pleasure of navigating an engaging discussion with Dr Harsh Hirani, Dr Sanjib Medhi, Dr Sushil Patel and Dr Mohsin Aslam. The panel explored how AI is already influencing diabetes care, how far we can trust AI-driven insights, the myths and ethical concerns surrounding its use, and whether technology can truly bring better healthcare closer to those who need it most. What made the session memorable was not just the science, but the clarity, honesty and practical wisdom shared by every panellist. Congratulations to all of them for such thoughtful deliberations. A very special appreciation goes to Dr Alok Modi, widely regarded as the “AI Man of India,” for brilliantly conceptualising and drafting the entire programme. My heartfelt thanks to Dr Sunil Gupta and Dr Kavita Gupta for organising this remarkable conference year after year, and to Dr Shlok Gupta for the warm hospitality. Kudos to the entire team for creating a platform where science, innovation and meaningful dialogue came together so beautifully.

24/06/2026

Delivered my talk on “Breaking Through Insulin Initiation Barriers with Premixes” at the 5th Annual Conference of API, Siliguri — a city that never fails to feel personal and special.

The session focused on a familiar challenge in type 2 diabetes care: we often know when insulin is needed, yet initiation is delayed.

Key takeaways:

• Timely insulin initiation can help reduce glucotoxicity and support better long-term glycemic control.
• In Indian and Asian patients, post-meal glucose spikes deserve special attention.
• Premix insulin can be a practical bridge between efficacy and simplicity, addressing both fasting and postprandial glucose needs.
• The right insulin choice is not only about numbers, but also about patient confidence, convenience, adherence, and quality of life.
• Overcoming clinical inertia requires better communication, structured follow-up, and individualized treatment plans.

The discussion reminded us that insulin should not be seen as a last resort, but as a timely tool when clinically appropriate.

Grateful to the organising committee for a beautifully conducted conference, warm hospitality, and a truly engaging scientific platform.

24/06/2026

Delivered my talk at the 5th Annual Conference of the Association of Physicians of India, Siliguri — a city that will always remain close to my heart.

It was a privilege to engage with colleagues and discuss evolving standards of care in type 2 diabetes.

Key takeaways from the session:

• Early and aggressive intervention in T2D can have long-term disease-modifying benefits.
• Weight management is increasingly recognized as a central therapeutic target, beyond glycemic control alone.
• Emerging evidence from the SURPASS program highlights the importance of achieving meaningful HbA1c reduction together with substantial weight loss.
• Individualized treatment strategies and a patient-centric approach remain essential for optimizing outcomes.
• The future of diabetes care lies in integrating efficacy, safety, and quality-of-life considerations into everyday clinical practice.

The scientific discussions, exchange of ideas, and enthusiasm from fellow physicians made the meeting truly memorable.

My sincere thanks to all the members of the Organising Committee for putting together such a wonderful conference and ensuring a seamless experience for delegates and faculty alike. Congratulations on an outstanding show.

Looking forward to many more meaningful scientific interactions with the API family.

19/06/2026

Can childhood obesity be prevented without fear, shame or extreme dieting?

This talk combines medicine, neuroscience, yoga and Indian wisdom to show that health is not about becoming thin—it's about becoming physically strong, mentally peaceful, socially kind and spiritually aware.

Simple message for students:
🍎 Eat good food
🏃 Move every day
😊 Stay happy
😴 Sleep well
📵 Control screen time

Students’ health is the nation’s health.

🎥 https://youtu.be/eQ_bjODxvmI?si=LQqcPXlPz_W51Y8t



https://youtu.be/eQ_bjODxvmI?si=nNg41tVAczcA16DS

19/06/2026

https://youtu.be/8DJ5sDUtWWA?si=tQMAW9CGaPfM2dWQ

Mind–Body–Spirit Connection in Diabetes CareDr Shambo Samrat Samaj...

19/06/2026

https://youtu.be/eQ_bjODxvmI?si=LQqcPXlPz_W51Y8t

Can obesity in children be prevented without fear, shame or extreme...

19/06/2026

Deprescribing in elderly diabetes: from “doing more” to “doing wisely.”

Our review highlights that polypharmacy affects up to 49% of older Indian adults, while adverse drug reactions contribute to nearly 1 in 10 hospitalizations—many potentially preventable. In late-life diabetes care, success should therefore extend beyond HbA1c to include safety, cognition, function, affordability, autonomy, and quality of life.

We propose the Clinical Pharmacological Reconciliation, Review, and Feedback (CPRRF) model, a structured 10-step framework for individualized deprescribing. The review also draws on Vedantic principles of discernment, restraint, and non-attachment—not as clinical evidence, but as a culturally resonant way to explain that stopping non-beneficial treatment is not abandonment of care. It is thoughtful refinement of care.

Key message: Deprescribing is not about giving less treatment. It is about removing what no longer serves the patient while preserving what supports function, dignity, and well-being.

Link to download: https://journals.lww.com/jiag/fulltext/2026/04000/deprescribing_in_elderly_diabetes__integrating.12.aspx

18/06/2026

Our article in today’s Indian Express reflects a simple but urgent message: India’s future will be built not only in laboratories, boardrooms and stadiums, but in the bodies, minds, breath, sleep, food choices and self-discipline of its children.

Yoga reminds us that health is not just fitness — it is rhythm, restraint, attention and fearless self-mastery.

Let “Abhih” become the new school health mantra: eat wisely, sleep well, move daily, use screens with discipline, and respect every body.

Because children’s health is India’s true national capital.
Link:
https://indianexpress.com/article/opinion/columns/put-indian-students-health-at-the-centre-of-nation-building-10745031/

17/06/2026

Honoured to deliver my talk on “Intermittent Fasting in Diabetes” at the 9th National Congress on Clinical Diabetes, organised by the Association of Clinical Diabetology, held at Hotel Hindustan International, Kolkata, on 13th–14th June 2026. A heartfelt thanks to Prof. Samar Banerjee Sir for organising this excellent academic endeavour and for creating a platform truly aligned with the congress theme — “Translating Science into Practice.”

My talk focused on a question that is highly relevant in current diabetes care: intermittent fasting is popular, but is it evidence-based, safe, and clinically useful for people with type 2 diabetes? The key message was that intermittent fasting is not one intervention, but a family of protocols — time-restricted eating, alternate-day fasting, whole-day fasting, and intermittent energy restriction. In diabetes, “try fasting” is never a complete prescription; the eating window, fasting duration, calorie target, medication plan, and monitoring strategy must all be defined.

Current evidence suggests that intermittent fasting may support weight loss and dietary structure, but it is not clearly superior to regular or continuous energy restriction for HbA1c, fasting glucose, or weight outcomes in type 2 diabetes. The most important clinical message was safety. In diabetes, intermittent fasting is not just a diet; it is a medication-management intervention. Patients on insulin, sulfonylureas, meglitinides, or SGLT2 inhibitors need particular attention, because medication adjustment, hydration advice, glucose or ketone monitoring when appropriate, and early reassessment are central to safe implementation.

The practical approach I shared was simple: define the phenotype, choose the lowest-risk protocol first, adjust medications before fasting begins, monitor clinically meaningful outcomes, and reassess at 2–4 weeks. Intermittent fasting should be positioned as an adherence tool with metabolic potential, not as a replacement for evidence-based diabetes, obesity, renal, or cardiovascular therapy.

My concluding message was: do not prescribe “fasting”; prescribe a monitored protocol. Adherence beats intensity. Safety beats enthusiasm.

Grateful to the organisers, chairpersons, faculty, and delegates for the engaging academic discussion and for the opportunity to contribute to this important conversation on individualized, evidence-based diabetes care.

17/06/2026

Eager to be part of the 13th Academia International Conclave at Nagpur — a true scientific feast bringing together innovation, evidence, education, collaboration, and impact in diabetes care.

Looking forward to contributing to the sessions on spirituality in diabetes care and artificial intelligence in clinical practice, and to engaging with esteemed colleagues from across the country.

My sincere thanks to Dr. Sunil Gupta sir for this opportunity.
Looking forward to the Nagpur assignments.